Home/Filings/4/0001209191-17-024356
4//SEC Filing

Xenetic Biosciences, Inc. 4

Accession 0001209191-17-024356

$XBIOCIK 0001534525operating

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 8:08 AM ET

Size

5.7 KB

Accession

0001209191-17-024356

Insider Transaction Report

Form 4
Period: 2017-04-03
PARSLOW JAMES F
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-04-03+175,000175,000 total
    Exercise: $4.57Exp: 2027-04-03Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option will vest and become exercisable over three years, with one-third of the underlying shares vesting on each of April 3, 2018, April 3, 2019 and April 3, 2020, subject to the Reporting Person's continuous service with the Issuer through each such date.

Issuer

Xenetic Biosciences, Inc.

CIK 0001534525

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001534525

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:08 AM ET
Size
5.7 KB